Migraine is a neurological condition characterized by recurring and sometimes severe headaches. Up to 18% of women get migraines, and they may have them more frequently when they are of childbearing age.1,2 Migraine often improves during pregnancy; however, this varies by whether women have migraine with aura (headaches accompanied by vision changes or tingling in your feet, hands, or face). This is less likely to get better during pregnancy.3,4.
Fill out the contact form to have a registry representative contact you with more information about this pregnancy registry.
Ask your healthcare provider to help you complete the contact form
In many women, pregnancy does not make the symptoms of migraine worse. About 87% of women who have migraine without aura will have improvement or remission (temporary recover) of migraine symptoms by their third trimester. However, migraine with aura is less likely to improve during pregnancy.3,4
There does not appear to be a clear reason why people develop migraine, but genetics, in addition to environmental and lifestyle factors, are thought to play a role. There is an increased chance of your child developing migraine if it runs in your family. Your child may develop the condition as he/she matures, but hopefully by that time research will have led to a greater understanding of migraine.5
Women should speak with their doctor about what medications are necessary to take during pregnancy. Healthcare providers and women are usually cautious about medicating while pregnant due to limited knowledge about the side effects of most medications during pregnancy. This is because pregnant women are frequently prohibited from participating in new clinical research studies to reduce risk to the pregnancy, delivery, or baby.
Pregnancy registries are studies designed to help healthcare providers learn more about medications and their effects on babies. They follow women who take medication knowingly during pregnancy or before they knew they were pregnant. The goal is to collect critical information that will help future women and their healthcare providers make informed decisions about their medication use before or during pregnancy.
Sharing your pregnancy information with this registry could help researchers learn whether taking Aimovig® (erenumab-aooe) shortly before or during pregnancy could affect the pregnancy or the baby’s health. It is not known at this time if Aimovig could harm your unborn baby. Currently, Aimovig is generally not being prescribed to expectant moms or women who plan to become pregnant.
If you are currently pregnant and taking Aimovig® (erenumab-aooe), contact your healthcare provider. They will decide if you should stop taking Aimovig®.
Learn about the GENESIS Pregnancy Registry here.
Your own healthcare provider should be the first source of information for you about your pregnancy and migraine. In addition, there are migraine patient advocacy groups where you can seek information from people who may have experience with migraine and pregnancy. Your healthcare provider may be able to help you contact a group that is active in your local area.
For the latest important safety information, please refer to the full Prescribing Information and Patient Information. This is not intended to replace discussions with your healthcare provider.
By clicking through the website, we understand this means you have accepted our cookies.